Literature DB >> 23053671

Aurora-B expression may not contribute to disease progression: a reflection of the heterogeneous pathogenesis?

Fabiola Fernandes Heredia, Juliana Cordeiro de Sousa, Alex Fiorini Carvalho, Silvia Maria Meira Magalhaes, Ronald Feitosa Pinheiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23053671      PMCID： PMC3487540          DOI： 10.3324/haematol.2012.068296

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

1.  High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia.

Authors:  Antonio R Lucena-Araujo; Fabio Morato de Oliveira; Sabrina Dias Leite-Cueva; Guilherme Augusto dos Santos; Roberto Passeto Falcao; Eduardo Magalhães Rego
Journal:  Leuk Res       Date:  2010-08-21       Impact factor: 3.156

2.  Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes.

Authors:  Akira Matsuda; Ulrich Germing; Itsuro Jinnai; Motohiro Misumi; Andrea Kuendgen; Sabine Knipp; Manuel Aivado; Masako Iwanaga; Yasushi Miyazaki; Hideki Tsushima; Mari Sakai; Masami Bessho; Masao Tomonaga
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

3.  Marked upregulation of Survivin and Aurora-B kinase is associated with disease progression in the myelodysplastic syndromes.

Authors:  Akira Yoshida; Kouichi Zokumasu; Yuji Wano; Takahiro Yamauchi; Shin Imamura; Kazutaka Takagi; Shinji Kishi; Yoshimasa Urasaki; Kaoru Tohyama; Takanori Ueda
Journal:  Haematologica       Date:  2012-03-14       Impact factor: 9.941

4.  Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia.

Authors:  Dongjiu Ye; Guillermo Garcia-Manero; Hagop M Kantarjian; Lianchun Xiao; Saroj Vadhan-Raj; Michael H Fernandez; Martin H Nguyen; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  J Hematop       Date:  2008-11-04       Impact factor: 0.196

5.  Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.

Authors:  Zhong-Zhe Lin; Yung-Ming Jeng; Fu-Chang Hu; Hung-Wei Pan; Hsin-Wei Tsao; Po-Lin Lai; Po-Huang Lee; Ann-Lii Cheng; Hey-Chi Hsu
Journal:  BMC Cancer       Date:  2010-08-28       Impact factor: 4.430

Review 6.  The Aurora kinases: role in cell transformation and tumorigenesis.

Authors:  Hiroshi Katayama; William R Brinkley; Subrata Sen
Journal:  Cancer Metastasis Rev       Date:  2003-12       Impact factor: 9.264

7.  Aurora A is differentially expressed and regulated in chromosomal and microsatellite instable sporadic colorectal cancers.

Authors:  Silke Lassmann; Mihai Danciu; Matthias Müller; Roland Weis; Frank Makowiec; Jürgen Schulte-Mönting; Ulrich T Hopt; Martin Werner
Journal:  Mod Pathol       Date:  2009-07-31       Impact factor: 7.842

8.  Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia.

Authors:  Xue-Fei Huang; Shao-Kai Luo; Jie Xu; Juan Li; Duo-Rong Xu; Li-Hui Wang; Min Yan; Xian-Ren Wang; Xiang-Bo Wan; Fei-Meng Zheng; Yi-Xin Zeng; Quentin Liu
Journal:  Blood       Date:  2007-12-26       Impact factor: 22.113
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.